We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Non-Invasive Tool for Removing Lung Cancer Tumors Reduces Surgical Trauma

By HospiMedica International staff writers
Posted on 05 Jun 2025

Surgical removal remains the gold standard for treating lung cancer, but current options—open surgery or needle-based microwave ablation—are invasive, traumatic, and require lengthy recovery periods. More...

Now, researchers are developing a novel technique that delivers microwave ablation via the airway, avoiding any skin penetration and potentially reducing post-operative trauma and recovery time.

This minimally invasive method, being developed at the University of Saskatchewan (USask, Saskatoon, Canada), reimagines how ablation can be performed by shifting the access point from the external chest wall to the body’s natural airways—either through the nose or mouth. While the concept of using the airway isn’t entirely new—existing biopsy tools already use this route—the innovation lies in applying it for therapeutic purposes such as tumor ablation. The team has proposed a device that can be inserted through the airway and navigated to the tumor site in the lung to deliver microwave energy. For this approach to be viable, the tool must be designed to be small, soft, and flexible enough to pass through the airway while still being capable of delivering effective ablation.

The research team is working closely with surgical professionals to guide the device’s development and ensure it meets practical clinical requirements, with a focus on sustainability and minimal invasiveness. Although still in development, the concept shows promise in transforming how early-stage lung tumors are treated. By eliminating the need for external incisions or needle insertions, this method could significantly shorten recovery times, reduce complications, and improve overall patient experience during lung cancer surgery. It also has the potential to make treatment more accessible to patients who are not good candidates for traditional surgery due to age or co-morbidities.

“Lung cancer is a very serious problem in Canada,” said Dr. Chris Zhang, PhD, who is leading the multidisciplinary team creating this new device. “I want this tool to add value by avoiding any significant complications with diagnosis and surgery.”

Related Links:
University of Saskatchewan


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
VTE Prevention System
Flowtron ACS900
New
Antimicrobial Mat
MULTIMAT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.